References
- Ahmad N, Alam MA, Ahmad R, et al. (2018). Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations. J Microencapsul 35:327–43.
- Amarji B, Garg NK, Singh SB, et al. (2016). Microemulsions mediated effective delivery of methotrexate hydrogel: more than a tour de force in psoriasis therapeutics. J Drug Target 24(2):1–14.
- Avachat AM, Parpani SS. (2015). Formulation and development of bicontinuous nanostructured liquid crystalline particles of efavirenz. Colloids Surf B Biointerfaces 126:87–97.
- Ayala A, Muñoz MF, Argüelles S. (2014). Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev 2014:360438.
- Beg S, Sharma G, Thanki K, et al. (2015). Positively charged self-nanoemulsifying oily formulations of olmesartan medoxomil: systematic development, in vitro, ex vivo and in vivo evaluation. Int J Pharm 493:466–82.
- Bishop KS, Kao CH, Xu Y, et al. (2015). From 2000 years of Ganoderma lucidum to recent developments in nutraceuticals. Phytochemistry 114:56–65.
- Bosch FX, Ribes J, Díaz M, et al. (2004). Primary liver cancer: worldwide incidence and trends. Gastroenterology 127:S5–S16.
- Choi HY, Chong SA, Nam MJ. (2009). Resveratrol induces apoptosis in human SK-HEP-1 hepatic cancer cells. Cancer Genomics Proteomics 6:263–8.
- Ding X, Xu X, Zhao Y, et al. (2017). Tumor targeted nanostructured lipid carrier co-delivering paclitaxel and indocyanine green for laser triggered synergetic therapy of cancer. RSC Adv 7:35086–95.
- Fernandez-Ros N, Iñarrairaegui M, Paramo JA, et al. (2015). Radioembolization of hepatocellular carcinoma activates liver regeneration, induces inflammation and endothelial stress and activates coagulation. Liver Int 35:1590–6.
- Garg NK, Singh B, Kushwah V, et al. (2016). The ligand (s) anchored lipobrid nanoconstruct mediated delivery of methotrexate: an effective approach in breast cancer therapeutics. Nanomedicine 12:2043–60.
- Garg NK, Singh B, Sharma G, et al. (2015). Development and characterization of single step self-assembled lipid polymer hybrid nanoparticles for effective delivery of methotrexate. RSC Adv 5:62989–99.
- Hann HW, Wan S, Myers RE, et al. (2012). Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients. PLoS One 7:e47687.
- Hietala J, Koivisto H, Anttila P, et al. (2006). Comparison of the combined marker GGT-CDT and the conventional laboratory markers of alcohol abuse in heavy drinkers, moderate dinkers and abstainers. Alcohol Alcohol 41:528–33.
- Iqbal M, Sharma SD, Okazaki Y, et al. (2003). Dietary supplementation of curcumin enhances antioxidant and phase II metabolizing enzymes in ddY male mice: possible role in protection against chemical carcinogenesis and toxicity. Pharmacol Toxicol 92:33–8.
- Jain A, Jain A, Garg NK, et al. (2015). Surface engineered polymeric nanocarriers mediate the delivery of transferrin–methotrexate conjugates for an improved understanding of brain cancer. Acta Biomater 24:140–51.
- Jain AK, Thanki K, Jain S. (2014). Novel self-nanoemulsifying formulation of quercetin: implications of pro-oxidant activity on the anticancer efficacy. Nanomedicine 10:959–69.
- Jain AK, Thanki K, Jain S. (2014). Solidified self-nanoemulsifying formulation for oral delivery of combinatorial therapeutic regimen: part II in vivo pharmacokinetics, antitumor efficacy and hepatotoxicity. Pharm Res 31:946–58.
- Jayakumar S, Madankumar A, Asokkumar S, et al. (2012). Potential preventive effect of carvacrol against diethylnitrosamine-induced hepatocellular carcinoma in rats. Mol Cell Biochem 360:51–60.
- Kang MH, Reynolds CP. (2009). Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res 15:1126–32.
- Khan R, Kazmi I, Afzal M, et al. (2015). Fixed dose combination therapy loperamide and niacin ameliorates diethylnitrosamine-induced liver carcinogenesis in albino Wistar rats. RSC Adv 5:67996–8002.
- Khurana S, Jain NK, Bedi PM. (2015). Nanostructured lipid carriers based nanogel for meloxicam delivery: mechanistic, in-vivo and stability evaluation. Drug Dev Ind Pharm 41:1368–75.
- Kim WR, Flamm SL, Di Bisceglie AM, et al. (2008). Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology 47:1363–70.
- Kimura Y, Taniguchi M, Baba K. (2002). Antitumor and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an active substance. Anticancer Res 22:3309–18.
- Kumar A, Ahuja A, Ali J, et al. (2016). Curcumin-loaded lipid nanocarrier for improving bioavailability, stability and cytotoxicity against malignant glioma cells. Drug Deliv 23:214–29.
- Kumar V, Bhatt PC, Rahman M, et al. (2017). Fabrication, optimization, and characterization of umbelliferone β-d-galactopyranoside-loaded PLGA nanoparticles in treatment of hepatocellular carcinoma: in vitro and in vivo studies. Int J Nanomedicine 12:6747–58.
- Kumar V, Bhatt PC, Rahman M, et al. (2017). Umbelliferon-α-d-glucopyranosyl-(2I→1II)-α-d-glucopyranoside ameliorates diethyl-nitrosamine induced precancerous lesion development in liver via regulation of inflammation, hyperproliferation and antioxidant at pre-clinical stage. Biomed Pharmacother 94:834–42.
- Lawrence TS, Robertson JM, Anscher MS, et al. (1995). Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 1:1237–48.
- Lemaire P, Drai P, Mathieu A, et al. (1991). Changes with different diets in plasma enzymes (GOT, GPT, LDH, ALP) and plasma lipids (cholesterol, triglycerides) of sea-bass (Dicentrarchus labrax). Aquaculture 93:63–75.
- Lin Z, Zhang H. (2004). Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms. Acta Pharmacol Sin 25:1387–95.
- Liu X, Hamnvik OP, Chamberland JP, et al. (2014). Circulating alanine transaminase (ALT) and γ-glutamyl transferase (GGT), but not fetuin-A, are associated with metabolic risk factors, at baseline and at two-year follow-up: the prospective Cyprus Metabolism Study. Metabolism 63:773–82.
- Lozoya-Agullo I, Araujo F, Gonzalez-Alvarez I, et al. (2018). PLGA nanoparticles are effective to control the colonic release and absorption on ibuprofen. Eur J Pharm Sci 115:119–25.
- Mitri K, Shegokar R, Gohla S, et al. (2011). Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance. Int J Pharm 414:267–75.
- Müller RH, Radtke M, Wissing SA. (2002a). Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 242:121–8.
- Müller RH, Radtke M, Wissing SA. (2002b). Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 54:S131–S55.
- Nair U, Bartsch H, Nair J. (2007). Lipid peroxidation-induced DNA damage in cancer-prone inflammatory diseases: a review of published adduct types and levels in humans. Free Radic Biol Med 43:1109–20.
- Pandey P, Rahman M, Bhatt PC, et al. (2018). Implication of nano-antioxidant therapy for treatment of hepatocellular carcinoma using PLGA nanoparticles of rutin. Nanomedicine (Lond) 13:849–70.
- Perz JF, Armstrong GL, Farrington LA, et al. (2006). The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 45:529–38.
- Prasad L, Khan TH, Jahangir T, et al. (2007). Abrogation of DEN/Fe-NTA induced carcinogenic response, oxidative damage and subsequent cell proliferation response by Terminalia chebula in kidney of Wistar rats. Pharmazie 62:790–7.
- Renugadevi J, Prabu SM. (2010). Cadmium-induced hepatotoxicity in rats and the protective effect of naringenin. Exp Toxicol Pathol 62:171–81.
- Sadek KM, Abouzed TK, Abouelkhair R, Nasr S. (2017). The chemo-prophylactic efficacy of an ethanol Moringa oleifera leaf extract against hepatocellular carcinoma in rats. Pharm Biol 55:1458–66.
- Sadek KM, Lebda MA, Nasr NE, et al. (2018). Role of lncRNAs as prognostic markers of hepatic cancer and potential therapeutic targeting by S-adenosylmethionine via inhibiting PI3K/Akt signaling pathways. Environ Sci Pollut Res Int 25:20057–70.
- Schieber M, Chandel NS. (2014). ROS function in redox signaling and oxidative stress. Curr Biol 24:R453–62.
- Sonawane R, Harde H, Katariya M, et al. (2014). Solid lipid nanoparticles-loaded topical gel containing combination drugs: an approach to offset psoriasis. Expert Opin Drug Deliv 11:1833–47.
- Thorgeirsson SS, Grisham JW. (2002). Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31:339–46.
- Valko M, Rhodes CJ, Moncol J, et al. (2006). Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem-Biol Interact 160:1–40.
- Verma A, Ahmed B, Anwar F, et al. (2017). Novel glycoside from Wedelia calendulacea inhibits diethylnitrosamine-induced renal cancer via downregulating the COX-2 and PEG2 through nuclear factor-κB pathway. Inflammopharmacology 25:159–75.
- Verma A, Singh D, Anwar F, et al. (2018). Triterpenoids principle of Wedelia calendulacea attenuated diethynitrosamine-induced hepatocellular carcinoma via down-regulating oxidative stress, inflammation and pathology via NF-kB pathway. Inflammopharmacology 26:133–46.
- Wang G, Zhao J, Liu JW, et al. (2007). Enhancement of IL-2 and IFN-gamma expression and NK cells activity involved in the antitumor effect of ganoderic acid Me in vivo. Int Immunopharmacol 7:864–70.
- Weng CJ, Chau CF, Yen GC, et al. (2009). Inhibitory effects of Ganoderma lucidum on tumorigenesis and metastasis of human hepatoma cells in cells and animal models. J Agric Food Chem 57:5049–57.